能動植込み型医療機器の世界市場規模：機器タイプ別、用途別、エンドユーザー別、地域別、予測

能動植込み型医療機器の市場規模と予測

能動植込み型医療機器の市場規模は、2024年に235億5,000万米ドルと評価され、2026～2032年にかけてCAGR 9.10%で成長し、2032年には472億7,000万米ドルに達すると予測されています。

能動植込み型医療機器の市場促進要因

能動植込み型医療機器市場の市場促進要因は、様々な要因の影響を受ける可能性があります。これらには以下のようなものが含まれます：

慢性疾患の蔓延：糖尿病、神経疾患、心血管疾患などの慢性疾患は、世界人口の高齢化とライフスタイルの変化に伴い、ますます一般的になってきています。AIMDは様々な疾患の管理において重要な役割を果たしています。ペースメーカー、植込み型除細動器（ICD）、神経刺激装置などがその例です。

技術開発：継続的な技術開発の結果、ますます複雑で効率的なAIMDが誕生しています。AIMDの機能性と信頼性を高めるこれらの開発には、小型化、電池の長寿命化、無線通信、センシング機能の強化などが含まれます。

低侵襲手術への嗜好の高まり：回復期間の短縮、合併症リスクの低減、患者の予後改善などの理由から、低侵襲手術法は患者やヘルスケア専門家の間でますます人気が高まっています。AIMDは患部に焦点を当てた治療を行うため、こうした手術に不可欠です。

ヘルスケア支出の増加：特に先進国におけるヘルスケア支出の増加により、AIMDのような新しい医療技術を購入できる人が増えています。政府のプログラムおよび償還ガイドラインにより、AIMDの使用がさらに促進される可能性があり、市場の拡大がさらに促進されると予想されます。

用途の拡大：AIMDは、神経学や心臓病学といった従来の医療分野以外でも、ますます多くの医療分野で使用されるようになっています。泌尿器科、整形外科、疼痛治療、さらには肥満管理への応用など、この拡大が新たな市場機会を生み出しています。

高齢者人口の増加：医療介入を頻繁に必要とする加齢に関連した健康問題は、世界人口の高齢化に伴い、より一般的になっています。その結果、筋骨格系障害、加齢性難聴、尿失禁などの病気を治療するAIMDの必要性が高まっています。

新興国市場：AIMDの市場は、新興国の可処分所得の増加とヘルスケアインフラの急速な改善により拡大しています。最先端の医療機器や治療に対する需要が高まっているため、これらの地域は大きな成長の可能性を秘めています。

患者のインプラントソリューション嗜好：患者は、処方薬や外付け器具のような従来型の治療よりも、埋め込み型の医療機器を好むことが多くあります。このような嗜好は、長期的な費用対効果、生活の質の向上、利便性といったものが動機として挙げられます。

能動植込み型医療機器の市場抑制要因

能動植込み型医療機器市場には、いくつかの要因が抑制要因や課題として作用する可能性があります。これらには以下のようなものがあります：

規制上の障害：製造業者は厳しい規制を遵守する上で大きな困難に直面します。米国のFDA（食品医薬品局）や欧州のCEマークのような規制機関から承認を得るには、長い時間と費用がかかります。

高価：高度な材料や技術を使用するため、埋め込み型医療機器の製造にはコストがかかります。これらの費用は顧客が負担するため、特に低開発国やヘルスケア資源の乏しい地域では、入手しやすさや購入しやすさが制限されます。

合併症と危険性：電気機器を体内に入れることには、感染症、機器の誤作動、組織拒絶反応の可能性など、多くの危険が伴います。特に代替療法がある場合には、こうした危険性を懸念して、患者やヘルスケア専門家がこれらの機器の使用を控えることもあります。

保険適用の制限：機器の種類、適応症、地域のヘルスケア規制によって、積極的植込み型医療機器に対する保険適用範囲は異なります。特に選択的治療の場合、保険適用が限定的であったり、償還が困難であったりするため、患者はこれらの医療機器を入手することが困難となる可能性があります。

技術的な困難：能動植込み型医療機器の機能性、安全性、寿命を向上させるには、大幅な技術的進歩が必要です。それにもかかわらず、バッテリー寿命、小型化、無線通信などの技術的障害は、創造性を妨げ、これらの機器の有用性を制限する可能性があります。

倫理とプライバシーの問題：データセキュリティと患者のプライバシーは、医療機器とコネクティビティ機能の統合によってもたらされる問題です。メーカーやヘルスケアプロバイダーにとって、個人医療情報の保護とデータプライバシー法の遵守は不可欠です。

限られた認識と採用：患者や医療提供者は、能動埋込み型医療機器の潜在的な利点を十分に認識していない可能性があります。このような医療機器の認知度を高め、適切な治療環境での使用を促すには、教育やアウトリーチの取り組みが必要です。

目次

第1章 イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 市場概要

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 能動植込み型医療機器市場：機器タイプ別

• 概要
• 植込み型除細動器（ICD）
• 心臓ペースメーカー
• 神経刺激装置
• 埋め込み型薬剤注入ポンプ
• 植込み型補聴器
• 植込み型心臓血管機器
• その他

第6章 能動植込み型医療機器市場：用途別

• 概要
• 心血管疾患
• 神経疾患
• 難聴
• 糖尿病管理
• 整形外科
• その他

第7章 能動埋め込み型医療機器市場：エンドユーザー別

• 概要
• 病院
• 外来手術センター（ASCs）
• 診療所および専門センター
• 在宅医療

第8章 能動埋め込み型医療機器市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• Cochlear Ltd.
• Zimmer Biomet
• LivaNova PLC
• Abbott
• Straumann AG
• Medtronic
• Stryker
• 3M
• Dentsply Sirona
• Allergan Inc

第11章 付録

• 関連調査

Active Implantable Medical Devices Market Size And Forecast

Active Implantable Medical Devices Market size was valued at USD 23.55 Billion in 2024 and is projected to reach USD 47.27 Billion by 2032, growing at a CAGR of 9.10% during the forecast period 2026-2032.

Global Active Implantable Medical Devices Market Drivers

The market drivers for the Active Implantable Medical Devices Market can be influenced by various factors. These may include:

Growing Prevalence of Chronic Diseases: Chronic diseases including diabetes, neurological problems, and cardiovascular diseases are growing increasingly common as the world's population ages and lifestyles alter. AIMDs play a critical role in the management of various disorders. Examples include pacemakers, implanted cardioverter defibrillators (ICDs), and neurostimulators.

Technological Developments: As a result of continuing technological developments, increasingly complex and efficient AIMDs have been created. These developments, which increase the functionality and dependability of these gadgets, include miniaturisation, longer-lasting batteries, wireless communication, and enhanced sensing capabilities.

Growing Preference for Minimally Invasive Surgery: Because of its shorter recovery periods, decreased risk of complications, and better patient outcomes, minimally invasive surgical methods are becoming more and more popular among patients and healthcare professionals. Because they provide focused therapy at the afflicted spot, AIMDs are essential to these procedures.

Growing Healthcare Expenditure: More people can now afford new medical technology, such as AIMDs, thanks to growing healthcare spending, especially in industrialised nations. Government programmes and reimbursement guidelines may further encourage the use of these devices, which would further propel market expansion.

Growing Application: AIMDs are being used in more and more medical fields outside of the more conventional ones, like neurology and cardiology. New market opportunities are being created by this expansion, which includes applications in urology, orthopaedics, pain treatment, and even obesity management.

Increasingly Ageing Population: Age-related health issues that frequently call for medical intervention are more common as the world's population ages. As a result, the need for AIMDs to treat ailments such musculoskeletal disorders, age-related hearing loss, and urine incontinence is rising.

Developing Markets: The market for AIMDs is growing as a result of emerging nations' growing disposable income and quickly improving healthcare infrastructure. Because there is a growing need for cutting-edge medical equipment and treatments, these areas have considerable potential for growth.

Implantable Solution Preference of Patients: Patients frequently favour implanted medical devices over more conventional forms of care like prescription drugs or external devices. This preference is frequently motivated by things like long-term cost-effectiveness, enhanced quality of life, and convenience.

Global Active Implantable Medical Devices Market Restraints

Several factors can act as restraints or challenges for the Active Implantable Medical Devices Market. These may include:

Regulatory Obstacles: Manufacturers face a great deal of difficulty in adhering to strict regulations. It can take a long time and money to get approvals from regulatory organisations like the FDA (Food and Drug Administration) in the US and the CE Mark in Europe.

Expensive: The production of active implantable medical devices can be costly due to the use of advanced materials and technologies. Customers bear the cost of these expenses, which restricts their accessibility and affordability, especially in underdeveloped nations or areas with tight healthcare resources.

Complications and dangers: Putting electrical devices into the body comes with a number of dangers, including the possibility of infection, device malfunction, and tissue rejection. Patients and healthcare professionals may be discouraged from using these devices due to concerns about these hazards, particularly if there are alternative therapies available.

Limited Coverage by Insurance: Depending on the type of device, the medical indication, and local healthcare regulations, insurance coverage for active implantable medical devices varies. Patients may find it difficult to obtain these devices due to limited coverage or difficulties with reimbursement, especially for elective treatments.

Technological Difficulties: Increasing the functionality, safety, and longevity of active implanted medical devices requires significant technological advancements. Nonetheless, technical obstacles like battery life, compact size, and wireless communication might hinder creativity and restrict the usefulness of these gadgets.

Ethical and Privacy Issues: Data security and patient privacy are issues that are brought up by the integration of medical equipment with connectivity characteristics. For manufacturers and healthcare providers, protecting private health information and making sure data privacy laws are followed are essential.

Limited Awareness and Adoption: Patients and healthcare providers may not be fully aware of the potential advantages of active implanted medical devices. To raise awareness of these devices and encourage their use in suitable therapeutic settings, education and outreach initiatives are required.

Global Active Implantable Medical Devices Market Segmentation Analysis

The Global Active Implantable Medical Devices Market is Segmented on the basis of Type of Device, Application, End-User, and Geography.

Active Implantable Medical Devices Market Segmentation Analysis

Active Implantable Medical Devices Market, By Type of Device

• Implantable Cardioverter Defibrillators (ICDs): Devices designed to monitor heart rhythm and deliver electrical shocks to restore normal heart rhythm in patients at risk of sudden cardiac arrest.
• Cardiac Pacemakers: Implantable devices that deliver electrical impulses to regulate heart rate and rhythm in patients with bradycardia or other heart rhythm disorders.
• Neurostimulators: Implantable devices that deliver electrical stimulation to specific nerves or areas of the brain to manage chronic pain, movement disorders (e.g., Parkinson's disease), epilepsy, and other neurological conditions.
• Implantable Drug Infusion Pumps: Devices that deliver medications directly into the body, typically used to manage chronic pain, spasticity, and other conditions requiring continuous drug delivery.
• Implantable Hearing Devices: Devices such as cochlear implants and bone-anchored hearing aids (BAHA) that restore hearing function in individuals with severe hearing loss or deafness.
• Implantable Cardiovascular Devices: Including implantable heart monitors, left ventricular assist devices (LVADs), and other devices used to monitor and support cardiovascular function in patients with heart failure and other cardiac conditions.
• Other Implantable Devices: Such as implantable glucose monitors for diabetes management, implantable drug-eluting stents for coronary artery disease, and implantable orthopedic devices for bone repair and joint replacement.

Active Implantable Medical Devices Market, By Application

• Cardiovascular Diseases: Devices used for the management of various cardiovascular conditions including arrhythmias, heart failure, and coronary artery disease.
• Neurological Disorders: Devices used to manage chronic pain, movement disorders, epilepsy, and other neurological conditions.
• Hearing Loss: Devices used to restore hearing function in individuals with severe hearing loss or deafness.
• Diabetes Management: Implantable glucose monitors and insulin pumps used for continuous glucose monitoring and insulin delivery in diabetic patients.
• Orthopedics: Implantable orthopedic devices for bone repair, joint replacement, and spinal stabilization.
• Others: Including implantable devices for urological disorders, gastrointestinal disorders, and other medical conditions.

Active Implantable Medical Devices Market, By End-User

• Hospitals: Including both general hospitals and specialized cardiac centers, neurological centers, and orthopedic centers where implantable medical devices are implanted and managed.
• Ambulatory Surgical Centers (ASCs): Facilities that perform outpatient procedures, including implantation of certain types of implantable medical devices.
• Clinics and Specialty Centers: Including cardiology clinics, neurology clinics, diabetes clinics, and other specialized healthcare facilities that provide diagnostic and therapeutic services related to implantable devices.
• Home Care Settings: Some implantable medical devices, such as insulin pumps and home monitoring devices, may be managed by patients themselves or by caregivers in home care settings.

Active Implantable Medical Devices Market, By Region

• North America: A major market for active implantable medical devices, driven by advanced healthcare infrastructure, high healthcare expenditure, and technological innovation.
• Europe: Europe has a significant market for active implantable medical devices, with a strong focus on cardiovascular and neurological applications.
• Asia-Pacific: Emerging market with growing demand for implantable medical devices, driven by increasing prevalence of chronic diseases and improving healthcare infrastructure.
• Latin America, Middle East, and Africa: Growing markets with expanding access to healthcare services and increasing adoption of advanced medical technologies.

Key Players

The "Global Active Implantable Medical Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Cochlear Ltd., Zimmer Biomet, LivaNova PLC, Abbott, Straumann AG, Medtronic, Stryker, 3M, Dentsply Sirona, Allergan Inc., Boston Scientific Corporation, BIOTRONIK SE & Co. KG, MED-EL, Sonova Holding AG, William Demant Holding A/S, and Nurotron Biotechnology Co., Ltd.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY TYPE OF DEVICE

• 5.1 Overview
• 5.2 Implantable Cardioverter Defibrillators (ICDs)
• 5.3 Cardiac Pacemakers
• 5.4 Neurostimulators
• 5.5 Implantable Drug Infusion Pumps
• 5.6 Implantable Hearing Devices
• 5.7 Implantable Cardiovascular Devices
• 5.8 Other Implantable Devices

6 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Cardiovascular Diseases
• 6.3 Neurological Disorders
• 6.4 Hearing Loss
• 6.5 Diabetes Management
• 6.6 Orthopedics
• 6.7 Others

7 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ambulatory Surgical Centers (ASCs)
• 7.4 Clinics and Specialty Centers
• 7.5 Home Care Settings

8 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Cochlear Ltd.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Zimmer Biomet
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 LivaNova PLC
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Abbott
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Straumann AG
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Medtronic
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Stryker
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 3M
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Dentsply Sirona
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Allergan Inc
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Research